Abstract. Previous studies in our laboratory demonstrated that 2 attenuated strains of transmissible gastroenteritis virus (TGEV) contain deletions affecting messenger (m) RNAs 2, 3, or 4. In this report, we have compared mRNAs of four modified-live virus vaccines for TGEV with the virulent Miller PP3 isolate to determine whether any transcriptional patterns are shared among attenuated strains. Using northern blot analysis, all vaccine viruses expressed mRNAs indistinguishable in size from those of Miller PP3. However, using S1 nuclease protection experiments, alterations in the regions of the genome from which mRNAs 2 and 3 are transcribed were detected in 2 of the vaccine strains. When genomic cDNA fragments derived from the coding region for mRNA 2 were sequenced, a 6-nucleotide deletion, also found in the attenuated strain Purdue-115, was discovered. The product of mRNA 2, a spike glycoprotein, was visualized by western blotting for each vaccine strain, and no profound differences in mobility were detected relative to Miller PP3. Alterations in the region of the genome from which mRNA 3 is transcribed appear to be identical or very similar to sequence alterations already described in this region for Purdue-115, one of which is likely to alter the polypeptide product of mRNA 3. Insertions or deletions in mRNAs 2 or 3 may contribute to attenuation but are not a prerequisite for this phenotype. The Sl nuclease protection analysis is a sensitive tool for differentiating particular strains of TGEV.
Transmissible gastroenteritis virus (TGEV) is a pleo-peplomers of TGEV. It is probably the mediator of morphic enveloped RNA virus with a single-stranded viral attachment to host cells, as has been demonstratpositive-sense genome belonging to the family Corona-ed for the S protein of another coronavirus, mouse viridae. 32 Classical TGEV strains are responsible for a hepatitis virus. 5 The S protein is the predominant insevere enteric disease in newborn piglets, with extremely high mortality. Recently, an attenuated respiratory variant of enterotropic TGEV, designated porcine respiratory coronavirus (PRCV), has emerged worldwide.
Replication of virulent TGEV is initiated with the synthesis of a full-length negative-sense RNA, which is subsequently used as a template for the discontinuous transcription of a nested set of at least 7 subgenomic messenger (m) RNAs. 17 These transcripts have identical polyadenylated 3' termini (see Fig. 1B ) and extend for various lengths in the 5' direction. They are numbered according to decreasing size.
Viral determinants of pathogenesis are not well understood, and although numerous TGEV vaccines have been proposed, none have proven entirely satisfactory and the disease remains a significant problem in the swine industry. 15, 23, 30 TGEV virions consist of 3 major structural proteins: the nucleocapsid protein (N), the integral membrane glycoprotein (M), and the large spike glycoprotein (S). The S protein is the product of mRNA 2 and forms the characteristic surface projections or ducer of neutralizing antibodies in swine and in other species l 1,14,18 and has been implicated in virulence and host cell tropism. l9 Our laboratory has previously reported genomic variations in the 2 open reading frames (ORFs) immediately downstream of the S gene in a TGEV smallplaque mutant. 36 Alterations in this region of the genome have also been reported for a number of PRCV strains. 1, 27, 37 Because both small-plaque TGEV and PRCV are attenuated and display altered tissue tropism, these features may be at least partly due to modification of the products of ORFs A and B (Fig. 1A) .
In the present study, we used northern blot analysis and S1 nuclease protection experiments to identify genomic differences between a virulent TGEV isolate and a group of attenuated vaccine strains. One of the aims of these experiments was to determine whether particular genes of attenuated TGEV strains consistently exhibit alterations, thus implicating them in virulence. We propose the use of S1 nuclease protection analysis as a sensitive method for detecting even small sequence differences among TGEV strains.
Materials and methods
From the USDA, Agricultural Research Service, National Animal Disease Center, Swine Virology Research Unit, Ames, IA 50010.
Viruses. The virulent Miller stock strain of TGEV was
Received for publication February 12, 1993. the sixth pig passage as an intestinal homogenate. Miller PP3 16 was derived from the virulent Miller stock following the third plaque purification. Vaccine strains, designated A, B, C, or D, were obtained from commercial sources or were provided by the manufacturer.
a-d The cell culture attenuated Purdue-115 strain was also analyzed.' Viruses were propagated on swine testicular (ST) cells grown in modified Eagle's minimal essential medium supplemented with 10% bovine fetal serum, 0.25% lactalbumin hydrolysate, 0.22% sodium bicarbonate, 0.01% sodium pyruvate, and 50 µg/ml gentamicin sulfate.
Intracellular RNAs. Total intracellular RNA was isolated from ST cells at approximately 17 hr postinfection by guanidinium isothiocyanante extraction and CsCl cushion centrifugation, as reported previously. 36 RNAs used for northern blotting were denatured with glyoxal and dimethyl sulfoxide prior to separation by agarose gel electrophoresis. Following capillary transfer to nylon membranes in 10 x standard saline citrate (SSC) (1 x SSC is 0.15 M NaCl, 0.015 M sodium citrate, pH 7.0) RNAs were cross-linked with UV light and hybridized as described previously with the 32 P end-labeled oligonucleotide HP-l, specific for the 3' end of the TGEV genome. 37 Dried filters were exposed to Kodak XAR-1 film at -80 C.
Plasmids and radiolabeledprobes. Plasmid pRP1 contains a previously characterized cDNA insert of 4,256 base pairs (bp) derived from the Miller PP3 strain. 36 This plasmid consists of 930 bp from the 3' end of the polymerase gene and roughly 75% of the 5' end of the S gene. The plasmid Hpa is a subclone of pRPl that contains the first 1,600 bp of the S gene. 36 Plasmid pRP3 codes for approximately 25% of the 3' end of the S gene and extends downstream through ORFs A, B, and C before terminating roughly 770 bp into the M gene. Unidirectional deletion mutants of pRP3 with successively shortened 3' ends were generated using an exonuclease III/mung bean nuclease deletion kit according to supplied procedures.
f These plasmids are designated Fl80 and B 180. Single-stranded runoff RNA probes were prepared using T3 or T7 polymerase, [-32 P]UTP, and linearized plasmids. S1 nuclease analysis. S1 nuclease protection experiments were carried out as previously described. 4 Intracellular RNAs in hybridization buffer were incubated with approximately 5 x 10 4 counts/min of the appropriate radiolabeled probe at 85 C for 10 min and then at 50 C overnight. Remaining single-stranded RNAs in the samples were digested at 37 C for 1 hr with 800 U/ml of S1 nuc1ease.
g Protected fragments were analyzed by agarose gel electrophoresis and autoradiography as detailed above.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting. Virions were crudely purified by differential centrifugation and stored at -80 C. Viral proteins were separated using a highly porous SDS-PAGE minigel system 8 except that the SDS concentration was reduced to 0.1% and ß-mercaptoethanol was omitted from the sample buffer. High-intensity electrophoretic transfer was done at 100 V for 2 hr with cooling. Membranes were subjected to a renaturation procedure by incubating at 37 C in Tris-buffered saline (TBS) for at least 16 hr. A solution of 5% skim milk in TBS with 0.05% Tween-20 (TBST) was used for a 1-hr blocking step at room temperature. After washing, ascites fluid from a mouse injected with S-specific 
hybridoma 4F6
38 was diluted in TBST with 1 M glucose and 10% glycerol and incubated with the membrane at 4 C overnight. Goat anti-mouse IgG conjugated to alkaline phosphatase secondary antibody h was detected with a commercial development kit. 
Reverse transcription polymerase chain reaction (PCR).
A thermostable reverse transcriptase RNA PCR kit j was used to generate cDNA fragments from the 5' end of the S gene of some attenuated TGEV strains. Total intracellular RNAs from infected ST cells served as templates. Initial negative strand synthesis was primed with an oligonucleotide complementary to bases 1,344-1,363 of the S gene. The forward reaction was primed with an oligonucleotide having the positive strand sequence of bases 917-931. The hot start procedure and amplification conditions used were those specified by the manufacturer. Final reaction products were analyzed on Nusieve 3: 1 k agarose gels to confirm the presence of a single band of the appropriate size.
cDNA sequencing. A PCR purification kit 1 was used to prepare reverse transcription PCR products for direct sequencing by a fluorescent chain-terminating dideoxynucleotide method. 26 The Genesis 2000 DNA analysis system m was used for electrophoresis and processing of sequencing reactions.
Results
Northern blot analysis. We compared the pattern of TGEV-specific intracellular RNAs from ST cells infected with attenuated strains to that of the virulent Miller PP3 strain. All vaccine viruses and the Purdue-115 strain exhibited transcripts indistinguishable in size from those of Miller PP3 (Fig. 2) . The TGEVspecific probe did not produce any detectable signal in lanes containing RNA prepared from uninfected ST cells (data not shown). Detection of variations in the S gene. S1 nuclease protection experiments were used for a more stringent comparison of mRNA 2 from virus PP3 and attenuated strains. Two radiolabeled RNA probes, RP1 and Hpa, were used and these are illustrated relative to their positions on the TGEV genome in Figure 1C .
Probe RP1, which includes sequence complementary to approximately 75% of the 5' end of the S gene, was completely protected from digestion by RNA from PP3 and vaccines C and D (Fig. 3A) . Fully protected probes could be weakly visualized (not visible in Fig.  3A ) as bands migrating with a size of approximately 4.25 kb. Longer exposures revealed these bands more clearly. Although northern blotting failed to demonstrate obvious differences in relative mobilities between RNA 2 from PP3 and that of vaccine A, vaccine B, and Purdue-115 viruses, incubation of probe RP1 with RNA from these three attenuated strains resulted in an identical pattern of 2 detectable bands with sizes of approximately 2.0 kb and 1.9 kb. These alterations were more precisely localized with the probe Hpa, a subclone of RP1 specific for the 5' region of the S gene (Fig. 1C) . As expected, virus isolates PP3, vaccine C, and vaccine D strains were capable of complete protection, whereas the remaining viral RNAs accomplished only partial protection (Fig.  3B) . Vaccine strains A and B and Purdue-115 RNAs again generated bands very similar in relative mobilities with sizes of about 1.0 kb and 0.4 kb. By aligning the Hpa-protected fragments with those protected by RP1, we predicted that, relative to PP3, these strains contained an insertion or deletion located roughly 1,000 bp from the 5' end of the S gene (Fig. 3C ).
Sequence analysis of the S gene. The nucleotide sequence of the S gene from the Purdue-115 strain has been previously published. 29 Comparison with PP3 sequence data revealed that Purdue-115 lacks 6 bp that are present in PP3 approximately 1.1 kb from the 5' terminus of the gene. 34 Cleavage of probes RP1 and Hpa at this site would generate fragments consistent with the sizes observed above. Viral RNAs from vaccines A and B were used as templates for reverse transcription PCR primed with oligonucleotides specific for this region of the S gene. Direct sequencing of the products confirmed that the 6-bp deletion from the Purdue-115 isolate is also a feature of vaccine strains A and B (data not shown). No other significant alterations from the sequence of PP3 in this area of the genome were evident. Western blot analysis. We compared the relative mobilities of the S protein from each strain in western blots using a previously described monoclonal antibody specific for antigenic site A, designated 4F6. 38 This site has been characterized by others as a conformational antigenic epitope. 7, 12 No reactivity was evident using standard SDS-PAGE and western blotting conditions with monoclonal antibody 4F6 (data not shown). By reducing the concentration of SDS, omitting ß-mercaptoethanol, and adding a renaturation procedure, the S protein of all but 2 vaccine strains was detectable (Fig. 4A) . The peplomer protein of the remaining viruses was only visible when samples were heated at 37 C, rather than being boiled, prior to electrophoresis (Fig. 4B) . No obvious differences in relative mobility were detected, indicating that the vaccine strains all produce an S protein similar in size to that of the PP3 and Purdue-115 strains. However, under the mildly denaturing and nonreducing conditions used separation may also have been affected by conformational or charge density differences.
S1 nuclease analysis of ORFs A and B.
Radiolabeled probes B180 and F180, homologous to the extreme 3' end of the S gene and extending downstream into ORFs A and B (Fig. 1C) , were hybridized to RNAs from the attenuated viruses to determine whether they were colinear with RNA from virus PP3. Both probes were completely protected from S1 nuclease digestion when incubated with RNAs from PP3, vaccine C, and vaccine D strains (Fig. 5A, lanes 2-4) . Incubation of probe B180 with Purdue-115, vaccine A, or vaccine B RNAs produced 2 fragments that were approximately 1.15 kb and 0.95 kb (Fig. 5A, lanes 5-7) . These three strains also partially protected probe F180, giving rise to fragments of roughly 1.15 kb and 0.7 kb (Fig. 5B, lanes 5-7) . Alignment of the protected fragments suggests that these 3 TGEV strains have a similar genomic alteration roughly located in the extreme 5' region of ORF A (Fig. 5C ).
Discussion
An S1 nuclease protection assay revealed the presence of a number of small alterations in the genomes of Purdue-115, vaccine A, and vaccine B viruses relative to the virulent PP3 strain. One of these alterations consists of a 6-bp deletion in the S gene that has already been described in Purdue-115 by other investigators. 13, 29 This deletion does not appear to fall within any of the major antigenic epitopes that have so far been characterized for TGEV. Currently, we have no evidence that the loss of these nucleotides contributes to the attenuated phenotype of the 3 strains. These 6 bp are also present in attenuated PRCV isolates from France and Britain 1,27 and in a US isolate (K.B. Register, unpublished data). Because no other major changes were detected in the S genes examined and western blotting results failed to uncover alterations in the mobility of the S protein, we can only conclude that insertions or deletions in this gene are not a prerequisite for loss of virulence in TGEV. However, the peplomer gene has been implicated in virulence in a number of other coronaviruses, including mouse hepatitis virus, 6,10,33 bovine coronavirus, 39 and feline coronaviruses, 9 and very likely plays a significant role in the pathogenesis of TGEV infection. Our sequence analysis of the 2 vaccine strains revealed occasional point mutations in the S gene. These mutations are unlikely to result in premature termination of transcription or significant alterations in glycosylation because the gene products did not display differences in relative mobilities. However, single base substitutions in other RNA viruses have been associated with profound changes in virulence, 21,25 and we cannot rule out this possibility with regard to TGEV.
A previous sequence comparison of ORFs A and B from Purdue-115 with that of the PP3 virus demonstrated the presence of 2 insertions in the Purdue-115 strain. The first is 16 bp long and lies in the noncoding region between the S gene and ORF A; the second is 29 bp in length and is located at the 3' end of ORF A 28, 35 These insertions would result in the generation of single-stranded loops in the target RNA during the hybridization step of S1 nuclease analysis. Regions of the radiolabeled PP3-derived probe located at the base of these loops might contain short single-stranded areas susceptible to S1 nuclease digestion. If cleavage of the probe occurred at both insertion sites, 3 protected fragments should result. The 2 protected bands observed for B180 and for F180 and the proposed location of the alteration (see Fig. 5C ) suggest that only the site of the smallest upstream insertion may be susceptible to digestion. Torsional constraints on a 16-nucleotide single-stranded loop could result in destabilization of homologous pairing at the base of the loop, leaving the probe susceptible to S1 nuclease cleavage. tigation, 4 virus-induced nonstructural proteins were detected in TGEV-infected cells, although none of them were consistent with the predicted size of either the ORF A or B product. 20 Others who have sequenced this region have likewise been unable to assign virusspecific proteins to these ORFS. 2, 35 Apparently, TGEV does not require the products of ORFs A and B for viral replication in tissue culture. 36, 37 Although we have shown a strong association between alterations in ORFs A and B and attenuation, the actual contribution of these gene products to virulence cannot be established by these experiments. However, when this genomic region of a British virulent field isolate was compared with that of Purdue-115, numerous differences were reported, some of which are identical to differences between our virulent Miller PP3 isolate and Purdue-115. 2, 35 Similar to our results using S gene-specific probes, when RNAs from Purdue-115, vaccine A, and vaccine B were hybridized to probes specific for the ORF A and B regions, we observed an identical pattern of partial protection. This pattern indicates a high degree of homology among these 3 strains and suggests that vaccines A and B have an insertion that is identical or very similar to the 16-bp insertion described for Purdue-115 in the noncoding region upstream from ORF A. Though not proven by our results, vaccines A and B probably also contain the 29-bp insertion found at the 3' end of the Purdue-115 ORF A. The predicted result of this insertion is a shift in reading frame that would increase the length of the ORF A product by 1 amino acid and would cause the C-terminal 6 amino acids to be different from those predicted for the ORF A product of PP3. 35 These observations in addition to previously published sequence data from a PRCV isolate and a small-plaque mutant, 36, 37 indicate that 5 of 7 attenuated strains that our laboratory has analyzed to date contain deletions, insertions, or substitutions in these 2 ORFs that would be expected to result in the modification or absence of their protein products.
Vaccine strains C and D completely protected all probes used for S1 protection experiments. Western blotting results support the hypothesis that the S genes of these 2 viruses are colinear with that of PP3. Because the TGEV ORF A and B products have not yet been identified, we are unable to determine whether these polypeptides from vaccine strains C and D are translated from their apparently full-length messages or whether they are different from those of PP3. We cannot eliminate the possibility of single base alterations in the S gene or ORFs A and B of these 2 strains that could affect protein function and, ultimately, viral phenotype.
The conservation of antigenic epitopes between most TGEV isolates, l6,22,3l including strains of PRCV, 3, 24 makes laboratory identification of specific TGEV strains extremely difficult and confounds attempts to monitor their prevalence and spread under field conditions. This study and previous studies 36, 37 have demonstrated the sensitivity of the S1 nuclease protection technique for identifying sequence differences among strains. We have consistently detected deletions as small as 3-6 bp, and at least some insertions are also apparent. Substitutions of several nucleotides or greater should also be evident. Although the number of strains characterized so far is relatively small, most of the attenuated viruses contain insertions or deletions relative to our virulent isolate. Therefore, this method may be useful as a tool for differentiating these 2 groups of viruses. We also observed specific patterns of protection associated with particular groups of attenuated strains, which suggests that S1 nuclease protection analysis may also be useful for the identification of specific strains of TGEV or at least for narrowing down the identity of an unknown isolate to 1 of a few strains.
